Updates in HCV Screening and Treatment
Key Issues Impacting OB/GYN Practice
Clinical Practice Guidelines
Testing Recommendations for Hepatitis C Virus Infection
Centers for Disease Control and Prevention.
A Guide to Comprehensive Hepatitis C Counseling and Testing.
Centers for Disease Control and Prevention.
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases/Infectious Diseases Society of America, 2017.
Hepatitis C in Pregnancy: Screening, Treatment, and Management.
Society for Maternal-Fetal Medicine
Hepatitis B and Hepatitis C in Pregnancy.
The American College of Obstetricians and Gynecologists
Hepatitis C: Screening.
U.S. Preventive Services Task Force, 2013.
Viral Hepatitis Surveillance - United States, 2015.
Centers for Disease Control and Prevention, 2015.
Suggested Readings
Suggested Reading
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland.
Aebi-Popp K, et al. J Virus Erad. 2016;2(1):52-54.
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.
Karampatou A, et al. J Hepatol. 2018;68(1):33-41.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
National Viral Hepatitis Action Plan 2017–2020.
U.S. Department of Health and Human Services, 2017.
The HCV care continuum does not end with cure: a call to arms for the prevention of reinfection.
Falade-Nwulia O, Sulkowski M. J Hepatol. 2017;66(2):267-269.
Treatment of HCV in persons who inject drugs: treatment as prevention.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Patient Resources
Patient Education Resources.
Centers for Disease Control and Prevention
Fact sheets for patients.
Hepatitis C and Injection Drug Use.
This webpage provides concise information regarding HCV risk, transmission, and prevention in people who inject drugs.
Relevant Resources
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Evolving Best Practices to Optimize Outcomes
The PCPs Role in Preventing HIV
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
The PCP’s Role in Timely Recognition and Referral
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
